Increasing the efficacy of tumor cell vaccines by enhancing cross priming. [electronic resource]
Producer: 20121107Description: 155-64 p. digitalISSN:- 1872-7980
- Antigens, Neoplasm -- immunology
- Apoptosis
- Autophagy
- Brain Neoplasms -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cancer Vaccines -- administration & dosage
- Clinical Trials as Topic
- Combined Modality Therapy
- Cross-Priming
- Dendritic Cells -- immunology
- Drug Design
- Glioma -- immunology
- Humans
- Immunization, Secondary
- Immunologic Memory
- Immunotherapy, Active
- Interferon-alpha -- biosynthesis
- Interleukin-12 -- biosynthesis
- Ligands
- Neoplasms -- therapy
- Receptors, Immunologic -- immunology
- Remission Induction
- Toll-Like Receptors -- immunology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.